$PMC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PharMerica CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PharMerica CORP. Get notifications about new insider transactions in PharMerica CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2015 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Sell | S | 33.62 | 6,530 | 219,510 | 40,461 | 47 K to 40.5 K (-13.90 %) |
May 19 2015 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 30.00 | 2,598 | 77,940 | 6,505 | 9.1 K to 6.5 K (-28.54 %) |
May 14 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 30.01 | 7,052 | 211,650 | 67,589 | 74.6 K to 67.6 K (-9.45 %) |
Mar 23 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 27.85 | 31,115 | 866,553 | 780,175 | 811.3 K to 780.2 K (-3.84 %) |
Mar 23 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 38,600 | 0 | 811,290 | 772.7 K to 811.3 K (+5.00 %) |
Mar 23 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 62,236 | 0 | 772,690 | 710.5 K to 772.7 K (+8.76 %) |
Mar 23 2015 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 27.85 | 2,685 | 74,777 | 46,991 | 49.7 K to 47 K (-5.41 %) |
Mar 23 2015 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Grant | A | 0.00 | 10,996 | 0 | 49,676 | 38.7 K to 49.7 K (+28.43 %) |
Mar 23 2015 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Grant | A | 0.00 | 7,345 | 0 | 38,680 | 31.3 K to 38.7 K (+23.44 %) |
Mar 23 2015 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 27.85 | 1,450 | 40,383 | 9,103 | 10.6 K to 9.1 K (-13.74 %) |
Mar 23 2015 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 2,363 | 0 | 10,553 | 8.2 K to 10.6 K (+28.85 %) |
Mar 23 2015 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 4,048 | 0 | 8,190 | 4.1 K to 8.2 K (+97.73 %) |
Mar 23 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 27.85 | 5,085 | 141,617 | 77,806 | 82.9 K to 77.8 K (-6.13 %) |
Mar 23 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 6,225 | 0 | 82,891 | 76.7 K to 82.9 K (+8.12 %) |
Mar 23 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 10,781 | 0 | 76,666 | 65.9 K to 76.7 K (+16.36 %) |
Mar 23 2015 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 27.85 | 1,701 | 47,373 | 29,857 | 31.6 K to 29.9 K (-5.39 %) |
Mar 23 2015 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Grant | A | 0.00 | 5,274 | 0 | 31,558 | 26.3 K to 31.6 K (+20.07 %) |
Mar 23 2015 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Grant | A | 0.00 | 4,794 | 0 | 26,284 | 21.5 K to 26.3 K (+22.31 %) |
Mar 23 2015 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Grant | A | 0.00 | 15,709 | 0 | 83,584 | 67.9 K to 83.6 K (+23.14 %) |
Mar 23 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.85 | 7,148 | 199,072 | 74,641 | 81.8 K to 74.6 K (-8.74 %) |
Mar 23 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 8,126 | 0 | 81,789 | 73.7 K to 81.8 K (+11.03 %) |
Mar 23 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 14,200 | 0 | 73,663 | 59.5 K to 73.7 K (+23.88 %) |
Mar 13 2015 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 26.22 | 1,200 | 31,464 | 31,335 | 32.5 K to 31.3 K (-3.69 %) |
Mar 13 2015 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 26.44 | 3,344 | 88,424 | 4,142 | 7.5 K to 4.1 K (-44.67 %) |
Mar 13 2015 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 26.22 | 304 | 7,971 | 7,486 | 7.8 K to 7.5 K (-3.90 %) |
Mar 13 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 26.22 | 837 | 21,946 | 65,885 | 66.7 K to 65.9 K (-1.25 %) |
Mar 13 2015 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 26.22 | 513 | 13,451 | 21,490 | 22 K to 21.5 K (-2.33 %) |
Mar 13 2015 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Payment of Exercise | F | 26.22 | 2,131 | 55,875 | 67,875 | 70 K to 67.9 K (-3.04 %) |
Mar 13 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 26.52 | 7,495 | 198,801 | 59,463 | 67 K to 59.5 K (-11.19 %) |
Mar 13 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 26.22 | 1,092 | 28,632 | 66,958 | 68.1 K to 67 K (-1.60 %) |
Mar 06 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Option Exercise | M | 18.48 | 28,360 | 524,093 | 0 | |
Mar 06 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Option Exercise | M | 10.84 | 24,546 | 266,079 | 8,183 | |
Mar 06 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Sell | S | 26.74 | 20,000 | 534,728 | 66,722 | 86.7 K to 66.7 K (-23.06 %) |
Mar 06 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 27.02 | 37,883 | 1,023,599 | 86,722 | 124.6 K to 86.7 K (-30.40 %) |
Mar 06 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Buy | M | 18.48 | 28,360 | 524,093 | 124,605 | 96.2 K to 124.6 K (+29.47 %) |
Mar 06 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Buy | M | 10.84 | 24,546 | 266,079 | 96,245 | 71.7 K to 96.2 K (+34.23 %) |
Mar 06 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 27.39 | 1,380 | 37,798 | 71,699 | 73.1 K to 71.7 K (-1.89 %) |
Mar 06 2015 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 27.39 | 589 | 16,133 | 7,790 | 8.4 K to 7.8 K (-7.03 %) |
Mar 06 2015 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 27.39 | 947 | 25,938 | 32,535 | 33.5 K to 32.5 K (-2.83 %) |
Mar 06 2015 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 27.39 | 970 | 26,568 | 22,003 | 23 K to 22 K (-4.22 %) |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 18.48 | 33,565 | 620,281 | 0 | |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 14.89 | 25,000 | 372,250 | 0 | |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 27.02 | 17,253 | 466,257 | 68,050 | 85.3 K to 68.1 K (-20.23 %) |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.39 | 46,229 | 1,266,212 | 85,303 | 131.5 K to 85.3 K (-35.15 %) |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 18.48 | 33,565 | 620,281 | 131,532 | 98 K to 131.5 K (+34.26 %) |
Mar 06 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 14.89 | 25,000 | 372,250 | 97,967 | 73 K to 98 K (+34.26 %) |
Mar 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | M | 15.10 | 85,500 | 1,291,050 | 0 | |
Mar 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 25.99 | 65,711 | 1,707,829 | 710,454 | 776.2 K to 710.5 K (-8.47 %) |
Mar 04 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | M | 15.10 | 85,500 | 1,291,050 | 776,165 | 690.7 K to 776.2 K (+12.38 %) |
Jan 22 2015 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 23.64 | 10,138 | 239,662 | 690,665 | 700.8 K to 690.7 K (-1.45 %) |
Jan 22 2015 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 23.64 | 1,381 | 32,647 | 33,482 | 34.9 K to 33.5 K (-3.96 %) |
Jan 22 2015 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 23.64 | 748 | 17,683 | 8,379 | 9.1 K to 8.4 K (-8.20 %) |
Jan 22 2015 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 23.64 | 2,008 | 47,469 | 73,079 | 75.1 K to 73.1 K (-2.67 %) |
Jan 22 2015 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 23.64 | 2,553 | 60,353 | 73,149 | 75.7 K to 73.1 K (-3.37 %) |
Oct 01 2014 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 24.79 | 771 | 19,113 | 22,973 | 23.7 K to 23 K (-3.25 %) |
Aug 12 2014 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Option Exercise | M | 16.16 | 13,600 | 219,776 | 0 | |
Aug 12 2014 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Sell | S | 26.55 | 8,399 | 223,002 | 43,561 | 52 K to 43.6 K (-16.16 %) |
Aug 12 2014 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Buy | M | 16.16 | 13,600 | 219,776 | 51,960 | 38.4 K to 52 K (+35.45 %) |
Aug 05 2014 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Payment of Exercise | F | 27.42 | 7,310 | 200,440 | 70,006 | 77.3 K to 70 K (-9.45 %) |
Jun 18 2014 | PMC | PharMerica CORP | OAKLEY ROBERT A | Director | Grant | A | 0.00 | 4,300 | 0 | 38,360 | 34.1 K to 38.4 K (+12.62 %) |
Jun 18 2014 | PMC | PharMerica CORP | MEYERS GEOFFREY G | Director | Grant | A | 0.00 | 4,300 | 0 | 34,778 | 30.5 K to 34.8 K (+14.11 %) |
Jun 18 2014 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Grant | A | 0.00 | 4,300 | 0 | 49,709 | 45.4 K to 49.7 K (+9.47 %) |
Jun 18 2014 | PMC | PharMerica CORP | LEPORE PATRICK G | Director | Grant | A | 0.00 | 4,300 | 0 | 15,856 | 11.6 K to 15.9 K (+37.21 %) |
Jun 18 2014 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Grant | A | 0.00 | 4,300 | 0 | 44,415 | 40.1 K to 44.4 K (+10.72 %) |
Jun 18 2014 | PMC | PharMerica CORP | DORR MARJORIE W | Director | Grant | A | 0.00 | 4,300 | 0 | 38,125 | 33.8 K to 38.1 K (+12.71 %) |
Jun 18 2014 | PMC | PharMerica CORP | Dahl W Robert Jr | Director | Grant | A | 0.00 | 4,300 | 0 | 39,510 | 35.2 K to 39.5 K (+12.21 %) |
Jun 18 2014 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Grant | A | 0.00 | 4,300 | 0 | 47,709 | 43.4 K to 47.7 K (+9.91 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 10.84 | 28,764 | 311,802 | 9,588 | |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 14.89 | 15,791 | 235,128 | 25,000 | |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 28.60 | 12,192 | 348,691 | 75,702 | 87.9 K to 75.7 K (-13.87 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.91 | 20,170 | 562,945 | 87,894 | 108.1 K to 87.9 K (-18.66 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 10.84 | 28,764 | 311,802 | 108,064 | 79.3 K to 108.1 K (+36.27 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.91 | 12,193 | 340,307 | 79,300 | 91.5 K to 79.3 K (-13.33 %) |
May 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 14.89 | 15,791 | 235,128 | 91,493 | 75.7 K to 91.5 K (+20.86 %) |
Mar 27 2014 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 27.02 | 10,198 | 275,550 | 700,803 | 711 K to 700.8 K (-1.43 %) |
Mar 27 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 27.02 | 2,166 | 58,525 | 75,702 | 77.9 K to 75.7 K (-2.78 %) |
Mar 27 2014 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 27.02 | 1,849 | 49,960 | 75,087 | 76.9 K to 75.1 K (-2.40 %) |
Mar 27 2014 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 27.02 | 468 | 12,645 | 9,127 | 9.6 K to 9.1 K (-4.88 %) |
Mar 27 2014 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 27.02 | 836 | 22,589 | 34,863 | 35.7 K to 34.9 K (-2.34 %) |
Mar 17 2014 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Sell | S | 26.27 | 60,000 | 1,576,470 | 711,001 | 771 K to 711 K (-7.78 %) |
Mar 14 2014 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Sell | S | 26.08 | 18,646 | 486,200 | 76,936 | 95.6 K to 76.9 K (-19.51 %) |
Mar 13 2014 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Payment of Exercise | F | 24.67 | 7,666 | 189,120 | 95,582 | 103.2 K to 95.6 K (-7.42 %) |
Mar 13 2014 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 6,863 | 0 | 103,248 | 96.4 K to 103.2 K (+7.12 %) |
Mar 13 2014 | PMC | PharMerica CORP | McKay Robert A | SVP Purchasing,Trad ... | Grant | A | 0.00 | 16,259 | 0 | 96,385 | 80.1 K to 96.4 K (+20.29 %) |
Mar 13 2014 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 25.22 | 3,812 | 96,146 | 9,595 | 13.4 K to 9.6 K (-28.43 %) |
Mar 13 2014 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 24.76 | 2,077 | 51,427 | 13,407 | 15.5 K to 13.4 K (-13.41 %) |
Mar 13 2014 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 2,606 | 0 | 15,484 | 12.9 K to 15.5 K (+20.24 %) |
Mar 13 2014 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Grant | A | 0.00 | 5,889 | 0 | 12,878 | 7 K to 12.9 K (+84.26 %) |
Mar 13 2014 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 24.76 | 45,891 | 1,136,261 | 771,001 | 816.9 K to 771 K (-5.62 %) |
Mar 13 2014 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 50,798 | 0 | 816,892 | 766.1 K to 816.9 K (+6.63 %) |
Mar 13 2014 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Grant | A | 0.00 | 90,811 | 0 | 766,094 | 675.3 K to 766.1 K (+13.45 %) |
Mar 13 2014 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Payment of Exercise | F | 24.76 | 3,762 | 93,147 | 35,699 | 39.5 K to 35.7 K (-9.53 %) |
Mar 13 2014 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Grant | A | 0.00 | 9,845 | 0 | 39,461 | 29.6 K to 39.5 K (+33.24 %) |
Mar 13 2014 | PMC | PharMerica CORP | Vishnubhatla Suresh | EVP, LTC Operations | Grant | A | 0.00 | 10,292 | 0 | 29,616 | 19.3 K to 29.6 K (+53.26 %) |
Mar 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 24.76 | 7,271 | 180,030 | 77,868 | 85.1 K to 77.9 K (-8.54 %) |
Mar 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 19,052 | 0 | 85,139 | 66.1 K to 85.1 K (+28.83 %) |
Mar 13 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Grant | A | 0.00 | 8,961 | 0 | 66,087 | 57.1 K to 66.1 K (+15.69 %) |
Mar 13 2014 | PMC | PharMerica CORP | FROESEL DAVID W JR | Executive VP, CFO & ... | Grant | A | 0.00 | 17,316 | 0 | 77,316 | 60 K to 77.3 K (+28.86 %) |
Mar 13 2014 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Grant | A | 0.00 | 4,180 | 0 | 23,744 | 19.6 K to 23.7 K (+21.37 %) |
Mar 11 2014 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 24.95 | 1,944 | 48,510 | 6,989 | 8.9 K to 7 K (-21.76 %) |
Mar 11 2014 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Sell | S | 24.93 | 10,000 | 249,295 | 45,409 | 55.4 K to 45.4 K (-18.05 %) |
Mar 07 2014 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Option Exercise | M | 14.89 | 37,192 | 553,789 | 0 | |
Mar 07 2014 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Option Exercise | M | 15.10 | 19,800 | 298,980 | 0 | |
Mar 07 2014 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 25.28 | 42,513 | 1,074,729 | 80,126 | 122.6 K to 80.1 K (-34.67 %) |
Mar 07 2014 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Buy | M | 14.89 | 37,912 | 564,510 | 122,639 | 84.7 K to 122.6 K (+44.75 %) |
Mar 07 2014 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Buy | M | 15.10 | 19,800 | 298,980 | 84,727 | 64.9 K to 84.7 K (+30.50 %) |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Option Exercise | M | 15.10 | 21,400 | 323,140 | 0 | |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 25.60 | 5,562 | 142,408 | 57,126 | 62.7 K to 57.1 K (-8.87 %) |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Sell | S | 25.59 | 8,795 | 225,071 | 62,688 | 71.5 K to 62.7 K (-12.30 %) |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 25.58 | 15,838 | 405,136 | 71,483 | 87.3 K to 71.5 K (-18.14 %) |
Mar 07 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Buy | M | 15.10 | 21,400 | 323,140 | 87,321 | 65.9 K to 87.3 K (+32.46 %) |
Mar 06 2014 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 25.20 | 585 | 14,742 | 8,933 | 9.5 K to 8.9 K (-6.15 %) |
Mar 06 2014 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Payment of Exercise | F | 25.20 | 946 | 23,839 | 19,324 | 20.3 K to 19.3 K (-4.67 %) |
Mar 06 2014 | PMC | PharMerica CORP | Lindemoen Mark | SVP Sales and Clien ... | Payment of Exercise | F | 25.20 | 970 | 24,444 | 19,564 | 20.5 K to 19.6 K (-4.72 %) |
Mar 06 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 25.20 | 1,831 | 46,141 | 65,921 | 67.8 K to 65.9 K (-2.70 %) |
Mar 06 2014 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 25.20 | 1,390 | 35,028 | 64,927 | 66.3 K to 64.9 K (-2.10 %) |
Mar 05 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 25.01 | 1,004 | 25,110 | 67,752 | 68.8 K to 67.8 K (-1.46 %) |
Mar 05 2014 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 25.01 | 848 | 21,208 | 66,317 | 67.2 K to 66.3 K (-1.26 %) |
Jan 23 2014 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 25.26 | 10,209 | 257,879 | 675,283 | 685.5 K to 675.3 K (-1.49 %) |
Jan 23 2014 | PMC | PharMerica CORP | Vishnubhatla Suresh | SVP and CTO | Payment of Exercise | F | 25.26 | 1,381 | 34,884 | 20,270 | 21.7 K to 20.3 K (-6.38 %) |
Jan 23 2014 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 25.26 | 745 | 18,819 | 9,518 | 10.3 K to 9.5 K (-7.26 %) |
Jan 23 2014 | PMC | PharMerica CORP | Caneris Thomas A | SVP, GC and Secreta ... | Payment of Exercise | F | 25.26 | 2,503 | 63,226 | 68,756 | 71.3 K to 68.8 K (-3.51 %) |
Jan 23 2014 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 25.26 | 1,961 | 49,535 | 67,165 | 69.1 K to 67.2 K (-2.84 %) |
Nov 19 2013 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Option Exercise | M | 16.31 | 15,424 | 251,565 | 0 | |
Nov 19 2013 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Payment of Exercise | F | 20.74 | 12,130 | 251,576 | 55,409 | 67.5 K to 55.4 K (-17.96 %) |
Nov 19 2013 | PMC | PharMerica CORP | MAC MAHON THOMAS P | Director | Buy | M | 16.31 | 15,424 | 251,565 | 67,539 | 52.1 K to 67.5 K (+29.60 %) |
Nov 25 2013 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Option Exercise | M | 16.31 | 15,424 | 251,565 | 0 | |
Nov 25 2013 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Sell | S | 20.56 | 3,271 | 67,248 | 40,115 | 43.4 K to 40.1 K (-7.54 %) |
Nov 25 2013 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Payment of Exercise | F | 20.70 | 12,153 | 251,567 | 43,386 | 55.5 K to 43.4 K (-21.88 %) |
Nov 25 2013 | PMC | PharMerica CORP | GERRITY THOMAS P | Director | Buy | M | 16.31 | 15,424 | 251,565 | 55,539 | 40.1 K to 55.5 K (+38.45 %) |
Nov 19 2013 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Option Exercise | M | 16.31 | 15,424 | 251,565 | 0 | |
Nov 19 2013 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Payment of Exercise | F | 20.74 | 12,130 | 251,576 | 43,409 | 55.5 K to 43.4 K (-21.84 %) |
Nov 19 2013 | PMC | PharMerica CORP | COLLINS FRANK E | Director | Buy | M | 16.31 | 15,424 | 251,565 | 55,539 | 40.1 K to 55.5 K (+38.45 %) |
Nov 15 2013 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Option Exercise | M | 16.31 | 300,553 | 4,902,019 | 0 | |
Nov 15 2013 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Payment of Exercise | F | 20.97 | 267,515 | 5,609,790 | 685,492 | 953 K to 685.5 K (-28.07 %) |
Nov 15 2013 | PMC | PharMerica CORP | WEISHAR GREGORY S | Chief Executive Off ... | Buy | M | 16.31 | 300,553 | 4,902,019 | 953,007 | 652.5 K to 953 K (+46.07 %) |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | M | 14.89 | 13,732 | 204,469 | 0 | |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | M | 15.10 | 4,762 | 71,906 | 0 | |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | M | 16.31 | 4,364 | 71,177 | 0 | |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Option Exercise | M | 18.48 | 7,705 | 142,388 | 2,568 | |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Sell | S | 20.55 | 4,097 | 84,193 | 10,263 | 14.4 K to 10.3 K (-28.53 %) |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Payment of Exercise | F | 20.25 | 26,466 | 535,937 | 14,360 | 40.8 K to 14.4 K (-64.83 %) |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Buy | M | 14.89 | 13,732 | 204,469 | 40,826 | 27.1 K to 40.8 K (+50.68 %) |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Buy | M | 15.10 | 4,762 | 71,906 | 27,094 | 22.3 K to 27.1 K (+21.32 %) |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Buy | M | 16.31 | 4,364 | 71,177 | 22,332 | 18 K to 22.3 K (+24.29 %) |
Nov 15 2013 | PMC | PharMerica CORP | Tomassetti Berard | SVP and CAO | Buy | M | 18.48 | 7,705 | 142,388 | 17,968 | 10.3 K to 18 K (+75.08 %) |
Nov 15 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Option Exercise | M | 16.31 | 62,661 | 1,022,001 | 0 | |
Nov 15 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Payment of Exercise | F | 20.97 | 53,826 | 1,128,731 | 69,126 | 123 K to 69.1 K (-43.78 %) |
Nov 15 2013 | PMC | PharMerica CORP | McKay Robert A | SVP of Trade Relati ... | Buy | M | 16.31 | 62,661 | 1,022,001 | 122,952 | 60.3 K to 123 K (+103.93 %) |
Nov 15 2013 | PMC | PharMerica CORP | Hernandez Anthony | SVP of Human Resour ... | Option Exercise | M | 16.31 | 38,563 | 628,963 | 0 |